tiprankstipranks
Lexicon Pharmaceuticals (LXRX)
NASDAQ:LXRX

Lexicon Pharmaceuticals (LXRX) Stock Investors

1,230 Followers
Based on 721,113 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold LXRX
On average, investors allocate 4.61% of their portfolios to LXRX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 721,113 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding LXRX

2.3%
Last 7
Days
7.4%
Last 30
Days
Percentages indicate the change in the number of portfolios holding LXRX, out of 721,113 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

LXRX Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.74%
$2.65
Increased
100.00%
$3.18
Opened
3.85%
$1.73
Increased
7.61%
$1.20
Increased
0.22%
$1.59
Based on the activity of 13,526 investors who made their portfolios public
The table shows changes in LXRX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

LXRX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Micron
5.41%
+0.88%
+9.88%
102.94B
Technology
DraftKings
7.07%
-0.19%
+1.70%
36.21B
Consumer Cyclical
AMC Entertainment
5.41%
-1.42%
-3.86%
1.17B
Communication Services
Marathon Digital Holdings
5.53%
-0.24%
+7.84%
5.17B
Financial
Coherus Biosciences
2.65%
-0.85%
-4.31%
247.23M
Healthcare
Riot Platforms
4.93%
+0.26%
+4.88%
2.94B
Financial
Merck & Company
4.05%
-0.34%
+0.58%
307.77B
Healthcare
ChargePoint Holdings
3.92%
-1.36%
-2.82%
702.29M
Consumer Cyclical
Assertio Therapeutics
2.71%
-1.00%
-4.39%
106.40M
Healthcare
Plug Power
4.90%
-0.55%
+1.62%
2.28B
Industrials
Based on the activity of 721,113 active portfolios
Open your Smart Portfolio

LXRX Investor Analysis

LXRX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.0%
of LXRX holders
are under 35
Average Segment Performance
Average P/E Ratio56.27
Beta7.29
Dividend Yield5.82%
LXRX investors between 35–55

Between 35–55

5.1%
Last 30 days
Holdings Change
60.0%
of LXRX holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.03
Beta10.97
Dividend Yield6.03%
LXRX investors over 55

Over 55

78.6%
Last 30 days
Holdings Change
31.0%
of LXRX holders
are over 55
Average Segment Performance
Average P/E Ratio53.58
Beta5.68
Dividend Yield6.19%
Overview of age group and performance of LXRX stock investors
See who invests in LXRX according to age group and performance.

FAQ

How many retail Investors hold LXRX?
<0.1% of TipRanks' retail investors hold LXRX in their portfolios.
    What is LXRX Investor Sentiment?
    LXRX’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of LXRX in the last 7 days?
      ▲ 2.3% of TipRanks' retail investors changed their holding of LXRX in the last 7 days.
        What percentage of retail investors changed their holding of LXRX in the last 30 days?
        ▲ 7.4% of TipRanks' retail investors changed their holding of LXRX in the last 30 days.
          What is the average age of retail investors who hold LXRX?
          The average age of LXRX Holders is between 35–55.
            What other stocks have LXRX investors also bought?
            LXRX Investors also bought MU, DKNG, AMC, MARA, CHRS, RIOT, MRK, CHPT, ASRT, PLUG.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Labs
              ATECAlphatec Holdings
              CORCencora
              NOTVInotiv
              BCRXBioCryst
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis